27 Apr 2019

In 10 Years, Half Of Middle-Income Elders Won’t Be Able To Afford Medical Care

By Victoria Knight In 10 years, more than half of middle-income Americans age 75 or older will not be able to afford to pay for yearly assisted living rent or medical expenses, according to a study published in Health Affairs in April.   The researchers used demographic and income data to project estimates

0
27 Apr 2019

Medical Researchers Seek Sage Advice Of Elders On Aging Issue

Rachel O’Conor booted up her slides and began posing questions to six older adults sitting around a table: How should primary care physicians support patients and caregivers after a diagnosis of dementia? And what stands in the way of getting adequate support? “Please speak louder and go slower,” suggested Susanne

0
24 Apr 2019

CHRONIC PAIN PATIENTS PUNISHED FOR OPIOID ABUSE BY DOCTORS, PHARMACIES, PAIN CLINICS; GOVERNMENT OVER REACTS

By Blake Farmer Nashville Public Radio A pharmacist in Celina, Tenn., was one of 60 people indicted on charges of opioid-related crimes in April  in a multistate sting. John Polston was charged with 21 counts of filling medically unnecessary narcotic prescriptions. He was also Gail Gray’s pharmacist and the person she relied

0
24 Apr 2019

CMS OUTLINES NEW PRIMARY CARE PAYMENT MODELS AIMED AT GREATER SHARED RISK APRIL 22

      The U.S. Centers for Medicare & Medicaid Services has proposed changes with several new primary care payment models, including one that would shift providers to global payments. The Trump Administration says it is building on the progress made over the last two years and further the CMS priority

0
22 Apr 2019

The AVLS NTNT Symposium will be June 1 in Atlanta

NTNT Symposium The NTNT Symposium will be June 1 in Atlanta. Non-thermal, non-tumescent ablation techniques have emerged as viable alternatives to more traditional options such as endovenous laser and radiofrequency ablation. Recent developments in reimbursement for these technologies make them even more appealing for clinicians treating venous disease.   The

0
22 Apr 2019

AVLS RECEIVING RESEARCH ABSTRACTS FOR 2019 ANNUAL CONGRESS EMERGING SCIENCE PROGRAM

           The American Vein & Lymphatic Society (AVLS) is accepting research abstracts for presentation at the AVLS 2019 Annual Congress. Access to emerging science in the medical field is essential for physicians to deepen clinical competence and improve their practice. The AVLS 2019 Annual Congress Emerging

0
13 Apr 2019

DABRA Excimer Laser Atherectomy to be Presented in Key Events at Charing Cross International Symposium

Ra Medical Systems Inc., headquartered in Carlsbad, California, has scheduled its key DABRA (Destruction of Arteriosclerotic Blockages by laser Radiation Ablation) Excimer Laser Atherectomy events at the upcoming Charing Cross International Symposium in London April 16–18. Ra Medical is in Booth No. 509. These events include case and podium presentations and

0
10 Apr 2019

LETHAL PLANS: When seniors turn to suicide in long-term care

      By Melissa Bailey and JoNel Aleccia When Larry Anders moved into the Bay at Burlington nursing home in late 2017, he wasn’t supposed to be there long. At 77, the stoic Wisconsin machinist had just endured the death of his wife of 51 years and a grim new diagnosis: throat

0
09 Apr 2019

AVLS to begin receiving research abstracts APRIL 17 for 2019 Annual Congress Emerging Science

The American Vein and Lymphatic Society (AVLS) will begin accepting research abstracts for presentation at the AVLS 2019 Annual Congress on April 17. Access to emerging science in the medical field is essential for physicians to deepen clinical competence and improve their practice. The AVLS 2019 Annual Congress Emerging Science

0
09 Apr 2019

 MERZ NORTH AMERICA REGAINS EXCLUSIVE DISTRIBUTION OF ASCLERA (POLIDOCANOL) INJECTION

  Merz North America Inc. has regained exclusive distribution of Asclera (polidocanol) Injection in the United States to all healthcare practitioners and phlebologists treating varicose veins, effective April 8. Also effective April 8th, AngioDynamics Inc. is no longer an authorized distributor of Asclera. All healthcare professionals will now be able

0